Houston-based Empower Pharmacy is one of two compounding pharmacies sued by the pharmaceutical giant Eli Lilly earlier this month for allegedly selling “knockoff” versions of its weight loss and diabetes drugs.
Lilly licensed orforglipron from Chugai in 2018. Now both companies’ stocks are soaring as the pill shows potential for blockbuster status in the weight-loss drug market. https://www.japantimes.co.jp/business/2025/04/18/companies/weight-loss-drug-orforglipron/?utm_medium=Social&utm_source=mastodon #business #companies #pharmaceuticals #obesity #mounjaro #ozempic #elililly #chugai #orforglipron #health
JPMorgan forecasts potential tactical rebound in U.S. stock market, identifying key stocks like Eli Lilly that could lead the trend amid trade negotiations and market volatility
#YonhapInfomax #JPMorgan #StockMarket #TacticalRebound #EliLilly #MarketVolatility #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=57838
Novo Nordisk's disappointing clinical trial results for advanced obesity treatment lead to sharp declines in Wegovy-related stocks, impacting both Novo Nordisk and competitor Eli Lilly
#YonhapInfomax #NovoNordisk #ClinicalTrial #Wegovy #ObesityTreatment #EliLilly #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=53688
Eli Lilly announces $27 billion investment in US manufacturing to meet rising demand for obesity and diabetes treatments, creating 10,000 jobs amid tariff concerns
#YonhapInfomax #EliLilly #ManufacturingInvestment #ObesityTreatment #DiabetesTreatment #USJobCreation #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=52300
Dokumente aus dem Gesundheitsministerium belegen: Das #Medizinforschungsgesetz wurde für die Firma #EliLilly geändert – trotz Warnungen aus dem eigenen Ministerium. #Pharma 
https://www.nd-aktuell.de/artikel/1186005.medizinforschungsgesetz-ein-gesetz-nur-fuer-lilly.html
Erleichtert die Bundesregierung dem US-Pharmakonzern #EliLilly das Geldverdienen, im Gegenzug für den Bau einer Fabrik? Vieles spricht dafür. https://www.investigate-europe.eu/de/posts/wunsch-von-eli-lilly?utm_medium=email
UK's Labour (!!!) government is to use jobless people as guinea pigs for a pharmaceutical trial #EliLilly https://www.independent.co.uk/news/health/weight-loss-drugs-nhs-tirzepatide-mounjaro-b2629171.html
Dokumente des #BMG:
"#Bundesregierung (fügte sich) der Forderung des #Pharmakonzern's #EliLilly (...), ein #Gesetz zu dessen Gunsten zu ändern. Im Gegenzug flossen Milliarden-#Investitionen."
#Gesundheit / #TödlichePreise
„Wunsch von Eli Lilly“
https://www.investigate-europe.eu/de/posts/wunsch-von-eli-lilly
Für ein paar Milliarden Euro kann man sich bei der Bundesregierung offenbar eine Gesetzesänderung kaufen – der US-#Pharmakonzern #EliLilly hat es vorgemacht, kommentiert Pauline Jäckels. https://www.nd-aktuell.de/artikel/1185999.gesetzesaenderung-us-pharmakonzern-eli-lilly-ein-deal-mit-dem-teufel.html
Wieder einmal zeigt sich #Scholz als Genosse der Bosse,sorgt persönlich dafür,dass ein Pharmakonzern seinen Wunsch nach Geheimpreisen bekommt&ganz Europa darunter leiden wird-alleine das deutsche Gesundheitssystem wird Milliarden verlieren.Und #Lauterbach ist wie immer rückratlos.
#EliLilly #spdlobbyismus #Pharmalobby
Lesenswerte Quelle:
https://www.sueddeutsche.de/projekte/artikel/politik/pharma-eli-lilly-mfg-lauterbach-scholz-e036761/
Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled in one of the biggest medical controversies in recent years. https://www.japantimes.co.jp/news/2024/09/21/world/science-health/alzheimers-drugs-controversy/ #worldnews #sciencehealth #dementia #aging #alzheimer039s #eisai #biogen #elililly #drugs #medicine #brain
"Some of the benefits appeared to last, however, only as long as patients were taking the drug."
Eli Lilly Says Weight-Loss Drug Sharply Reduces Diabetes Progression
The drug also led to significant weight reduction
Weekly injections of Zepbound for more than 3 years reduced the risk of progression to Type 2 diabetes by 94%, compared with a placebo, among people with excess weight and prediabetes.
Japan's health ministry is expected to soon approve new Alzheimer’s drug donanemab after a ministry panel backed the move. https://www.japantimes.co.jp/news/2024/08/02/japan/science-health/alzheimers-donanemab-approval-expected/ #japan #sciencehealth #elililly #alzheimer039s #pharmaceuticals #health #mentalhealth #dementia #medicine #donanemab
“You could argue this is just as important as the discovery of CPAP therapy 40 odd years ago,” referring to continuous positive airway pressure.
Why Curing Sleep Apnea Would Push Insurers to Pay for Weight-Loss Drugs
The New Holy Grail for Weight-Loss Drugs Is Sleep Apnea
Popular anti-obesity medicines are in testing for a range of other diseases. Positive results could prompt more insurers to pay up.
Via #CNN
The US #FoodAndDrugAdministration on Tuesday approved #donanemab, a #MonoclonalAntibody designed to slow the progression of early symptomatic #Alzheimer’s disease
Donanemab, made by #Indianapolis-based #EliLilly, works by helping body remove #AmyloidPlaque buildup in the brain, a hallmark of Alzheimer’s disease
It will be sold under the name #Kisunla and would cost $695/vial b4 insurance, what would amount to $12,522 for a 6-month course
https://www.cnn.com/2024/07/02/health/lilly-azheimers-donanemab-fda/index.html
"A unanimous panel of [U.S.] federal drug advisers on Monday concluded that Eli Lilly's experimental Alzheimer's drug donanemab benefits patients with early stages of the disease and that its benefits outweigh its risks."
@AxiosNews reports: https://flip.it/7_GWD0
Alphabet named Eli Lilly & Co. executive Anat Ashkenazi as its new chief financial officer. Ashkenazi’s background in health care may play a part in boosting Alphabet’s reputation in a sector it's been trying to revolutionize for years. https://www.japantimes.co.jp/business/2024/06/06/companies/alphabet-eli-lilly-cfo-porat/ #business #companies #alphabet #elililly #ruthporat #socialmedia
Ein #Ampel-Gesetz soll es Pharmafirmen ermöglichen, ihre Preise geheimzuhalten. Das nützt eigentlich fast niemandem – außer dem Untenehmen #EliLilly. Dessen #Lobbyisten haben offenbar einen guten Draht zu Scholz und Co. https://www.nd-aktuell.de/artikel/1182238.lobbyismus-schreiben-pharmakonzerne-in-unseren-gesundheitsgesetzen-mit.html
:
